Interleukin 6 mediates production of interleukin 10 in metastatic melanoma Mizue TeraiMasumi EtoTakami Sato Original article 19 August 2011 Pages: 145 - 155
Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001 Eleni-Kyriaki VetsikaGeorgios KonsolakisDimitris Mavroudis Original article 20 August 2011 Pages: 157 - 168
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients Ray WilkinsonKatherine WoodsKristen J. Radford Original article 27 August 2011 Pages: 169 - 179
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy Rieneke van de VenAnneke W. ReursTanja D. de Gruijl Original article 27 August 2011 Pages: 181 - 191
The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors Mark-Alexander SchwarzbichMichael GutknechtFrank Grünebach Original article 27 August 2011 Pages: 193 - 202
Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory Jang-June ParkSudarshan AnandKoji Tamada Original article 30 August 2011 Pages: 203 - 214
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin Abhishek D. GargDmitri V. KryskoPatrizia Agostinis Short communication 23 December 2011 Pages: 215 - 221
Regulatory dendritic cells in the tumor immunoenvironment Galina V. ShurinCamille E. OuelletteMichael R. Shurin Focussed Research Review 08 November 2011 Pages: 223 - 230
MicroRNA regulation in cancer-associated fibroblasts Olga AprelikovaJeffrey E. Green Focussed Research Review 16 November 2011 Pages: 231 - 237
Immunological monitoring of the tumor immunoenvironment for clinical trials Anatoli M. MalyguineSusan L. StroblMichael R. Shurin Focussed Research Review 12 November 2011 Pages: 239 - 247
Novel insights into the molecular mechanisms of HLA class I abnormalities Barbara Seliger Focussed Research Review 27 November 2011 Pages: 249 - 254
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients Paola FilipazziVeronica HuberLicia Rivoltini Focussed Research Review 27 November 2011 Pages: 255 - 263
Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells Anahid JewettHan-Ching Tseng Focussed Research Review 25 November 2011 Pages: 265 - 274
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation Viktor UmanskyAlexandra Sevko Focussed Research Review 27 November 2011 Pages: 275 - 282
Disarming suppressor cells to improve immunotherapy Theresa L. Whiteside Focussed Research Review 07 December 2011 Pages: 283 - 288
Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells Arthur A. HurwitzStephanie K. Watkins Focussed Research Review 12 January 2012 Pages: 289 - 293
From cell regulation to patient survival: 2nd Cancer immunotherapy and immunomonitoring (CITIM) meeting, Budapest, 2–5 May 2011 Viktor UmanskyAnatoli MalyguineMichael R. Shurin Meeting report 28 September 2011 Pages: 295 - 301